David P. Luci - Jun 24, 2021 Form 3 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ David P. Luci
Stock symbol
ACXP
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
3
Date filed
6/24/2021, 06:23 PM
Next filing
Jul 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACXP Common Stock 1M Jun 24, 2021 Direct F1
holding ACXP Common Stock 15.1K Jun 24, 2021 By spouse F1
holding ACXP Common Stock 35K Jun 24, 2021 By child F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACXP Warrants for Common Stock Jun 24, 2021 Common Stock 6.25K $2.00 Direct F1
holding ACXP Warrants for Common Stock Jun 24, 2021 Common Stock 7.5K $3.00 Direct F1
holding ACXP Warrants for Common Stock Jun 24, 2021 Common Stock 3.13K $4.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the conversion of membership interests to common stock pursuant to the corporate conversion of Acurx Pharmaceuticals, Inc.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney